V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10318103 | 10039412 | 1.69 | 39.35 | null | 2019-05-13 | 2019-05-31 | R GCVP | 02 | N | POMALIDOMIDE | 101259936 |
| 10318122 | 10039413 | 1.55 | 104 | null | 2016-06-03 | 2016-06-14 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | SUNITINIB | 101315589 |
| 10318129 | 10039414 | 1.66 | 88.2 | null | 2022-03-09 | 2022-03-14 | Sunitinib | N | null | BUSULFAN | 100520997 |
| 10318138 | 10039415 | 1.9 | 100.5 | 03 | 2019-03-27 | 2019-04-24 | Gemcitabine + Capecitabine | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100799182 |
| 10318144 | 10039416 | 1.75 | 69.4 | null | null | 2017-07-25 | Capecitabine + Cisplatin | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100177840 |
| 10318159 | 10039417 | 1.73 | 56.4 | 03 | 2011-08-19 | 2019-05-19 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100405811 |
| 10318231 | 10039419 | 1.67 | 80.5 | Palliative (P) | 2018-10-31 | 2019-01-23 | CLADRIBINE | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101338563 |
| 10318278 | 10039420 | 1.92 | 117.5 | Palliative (P) | 2021-02-03 | 2021-02-07 | CLADRIBINE | 02 | null | PAZOPANIB | 100269676 |
| 10318283 | 10039421 | 0 | 0 | 03 | null | 2018-03-12 | Cyclophosphamide + Docetaxel | null | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101592344 |
| 10318310 | 10039422 | 1.75 | 63.3 | Palliative (P) | 2018-09-09 | 2018-09-24 | Sunitinib | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100996145 |
| 10318362 | 10039424 | 1.56 | 75.6 | Curative (C) | 2018-01-19 | 2018-01-29 | CYTARABINE | 02 | null | CLADRIBINE | 101156326 |
| 10318370 | 10039425 | 1.65 | 72 | 03 | 2018-02-03 | 2018-02-04 | FLUOROURACIL | 02 | null | FLUOROURACIL | 100349088 |
| 10318663 | 10039429 | 1.68 | 86 | Adjuvant (A) | 2018-10-30 | 2018-11-07 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101028200 |
| 10318691 | 10039430 | 1.8 | 69.3 | Adjuvant (A) | 2021-05-27 | 2021-05-31 | DABRAFENIB + TRAMETINIB | 02 | N | CAPECITABINE + GEMCITABINE | 101001809 |
| 10318702 | 10039431 | 0.9 | 0 | Adjuvant (A) | 2018-07-19 | 2018-08-02 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100428841 |
| 10318744 | 10039432 | 1.74 | 64.8 | Palliative (P) | 2018-05-02 | 2018-05-11 | Carboplatin + Pembrolizumab + Pemetrexed | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100917736 |
| 10318779 | 10039433 | 1.52 | 59 | Palliative (P) | 2020-06-25 | 2020-06-28 | FLUOROURACIL | null | N | FLUOROURACIL | 100966829 |
| 10318813 | 10039434 | 1.67 | 84 | Adjuvant (A) | 2020-06-20 | 2020-06-26 | Cyclophosphamide + Docetaxel | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100441879 |
| 10318898 | 10039436 | 1.6 | 65.2 | Neo-adjuvant (N) | 2018-12-28 | 2019-01-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100795384 |
| 10319033 | 10039443 | 1.81 | 90.7 | 03 | 2017-01-14 | 2017-01-20 | Acalabrutinib | N | N | ACALABRUTINIB | 101066367 |
| 10319060 | 10039445 | 1.84 | 91.3 | Not known (9) | 2018-09-11 | 2018-09-11 | FLUOROURACIL + IRINOTECAN | 02 | Y | FLUOROURACIL + IRINOTECAN | 101090801 |
| 10319128 | 10039447 | 1.6 | 70 | Palliative (P) | 2017-05-22 | 2017-05-29 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100469830 |
| 10319218 | 10039449 | 1.75 | null | Palliative (P) | 2017-08-31 | 2017-09-08 | DABRAFENIB + TRAMETINIB | 02 | Y | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101158355 |
| 10319240 | 10039450 | null | 0 | 02 | 2019-02-24 | 2019-03-05 | Capecitabine + Cisplatin | 02 | N | CVP R | 101812679 |
| 10319262 | 10039451 | 1.84 | 82.3 | Palliative (P) | 2019-04-13 | 2019-04-25 | Palbociclib | null | N | PALBOCICLIB | 101500619 |
| 10319313 | 10039454 | 1.73 | 72 | Adjuvant (A) | 2019-09-19 | 2019-09-19 | Cytarabine Low Dose | null | N | CAPECITABINE + GEMCITABINE | 100715766 |
| 10319385 | 10039455 | 0 | 78 | Adjuvant (A) | 2018-08-17 | 2018-09-05 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 100198585 |
| 10319390 | 10039456 | null | 0 | Curative (C) | 2018-07-26 | 2019-07-21 | CHOP - 21 days | 02 | null | FLUOROURACIL | 100008611 |
| 10319452 | 10039458 | 1.64 | null | null | 2018-01-09 | 2018-01-09 | BUSULFAN | 02 | null | POMALIDOMIDE | 100124092 |
| 10319598 | 10039459 | null | null | Palliative (P) | 2018-10-19 | 2018-11-23 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CISPLATIN + FLUOROURACIL | 101467129 |
| 10319622 | 10039460 | 1.82 | 68.1 | Palliative (P) | 2019-02-20 | 2019-03-04 | CHOP R - 21 days | 02 | N | CHOP R | 100471829 |
| 10319637 | 10039461 | 1.72 | 95.8 | null | 2019-06-11 | 2019-06-14 | NIVOLUMAB | 99 | null | NIVOLUMAB | 101700454 |
| 10319691 | 10039463 | 1.82 | 0 | null | 2019-11-25 | 2019-11-25 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100818205 |
| 10319694 | 10039464 | 1.67 | 89.2 | Palliative (P) | 2019-08-13 | 2019-08-16 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100265271 |
| 10319707 | 10039465 | 1.63 | 83 | Palliative (P) | 2019-07-01 | 2019-07-08 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101810622 |
| 10319711 | 10039466 | 1.84 | 65 | Adjuvant (A) | 2019-09-29 | 2019-09-29 | Pazopanib | 02 | N | BUSULFAN | 100366728 |
| 10319795 | 10039467 | 1.82 | 85.5 | null | 2020-02-13 | 2020-02-13 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100070218 |
| 10319822 | 10039468 | 1.62 | 86.4 | Disease modification (D) | null | 2017-08-25 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100208164 |
| 10319841 | 10039469 | 1.56 | 64 | Palliative (P) | 2020-02-15 | 2020-02-28 | Cyclophosphamide + Docetaxel | null | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100262203 |
| 10319848 | 10039470 | null | null | null | 2019-05-29 | 2019-06-11 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101260791 |
| 10319885 | 10039471 | 1.48 | 61 | Palliative (P) | 2021-01-24 | 2021-02-04 | Fluorouricil + Folonic Acid (MdG) | 2 | N | FLUOROURACIL | 101134153 |
| 10319938 | 10039472 | 0 | 0 | Palliative (P) | 2020-04-02 | 2020-04-26 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100501486 |
| 10320075 | 10039474 | 1.61 | 76 | null | 2017-04-08 | 2017-04-10 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100912417 |
| 10320107 | 10039475 | null | 0 | null | 2022-05-09 | 2022-05-19 | Cladribine IV (5 day) | 02 | null | BCG | 100189401 |
| 10320116 | 10039476 | 1.75 | 94.6 | null | 2018-06-07 | 2018-07-04 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101535074 |
| 10320170 | 10039477 | 1.72 | 58 | Curative (C) | 2020-01-18 | 2020-01-18 | Cisplatin + Vinorelbine (IV) | 02 | N | MITOMYCIN | 100120815 |
| 10320173 | 10039478 | 1.52 | 60.4 | 03 | 2018-09-06 | 2018-09-11 | R GCVP | 02 | N | TRIAL | 101159344 |
| 10320182 | 10039479 | 1.76 | 97 | null | 2018-07-24 | 2018-07-28 | CHOP R - 21 days | 02 | null | CHOP R | 100871856 |
| 10320293 | 10039480 | 0 | 96 | Palliative (P) | 2017-06-19 | 2017-06-26 | Pazopanib | 02 | Y | CAPECITABINE + CISPLATIN | 101266062 |
| 10320294 | 10039481 | 1.58 | 85.3 | Adjuvant (A) | 2019-01-19 | 2019-02-02 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101129109 |